ATR-006

N/A

Report date: 2025/01/26 19:29:50
NME

Base Information

Drug NameATR-006
Drug Alias NameMEK pathway inhibitor (Atriva Therapeutics)ATR-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveRespirovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtriva Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesAtriva Therapeutics Gmbh
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveRespirovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A